Intelligent Bio Solutions Stock Today
| INBS Stock | USD 9.87 3.94 28.53% |
PerformanceFair
| Odds Of DistressSmall
|
Intelligent Bio is selling for under 9.87 as of the 22nd of January 2026; that is 28.53% down since the beginning of the trading day. The stock's lowest day price was 9.52. Intelligent Bio has about a 26 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2025 and ending today, the 22nd of January 2026. Click here to learn more.
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Intelligent Bio operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 1.22 M outstanding shares of which 128.61 K shares are currently shorted by private and institutional investors with about 0.03 trading days to cover. More on Intelligent Bio Solutions
Moving together with Intelligent Stock
Moving against Intelligent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Intelligent Stock Highlights
Intelligent Bio Solutions (INBS) is traded on NASDAQ Exchange in USA and employs 53 people. Intelligent Bio is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.79 M. Intelligent Bio Solutions conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 1.22 M outstanding shares of which 128.61 K shares are currently shorted by private and institutional investors with about 0.03 trading days to cover.
Intelligent Bio Solutions currently holds about 8.28 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Check Intelligent Bio Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Intelligent Bio is $16.79 Million. Roughly 88.11 (percent) of Intelligent Bio outstanding shares are held by general public with 0.77 % owned by insiders and only 11.12 pct. by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Intelligent Ownership Details
Intelligent Bio Solutions Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Intelligent Bio market risk premium is the additional return an investor will receive from holding Intelligent Bio long position in a well-diversified portfolio.
| Mean Deviation | 9.23 | |||
| Semi Deviation | 8.1 | |||
| Standard Deviation | 19.87 | |||
| Variance | 394.88 |
Intelligent Stock Against Markets
Intelligent Bio Corporate Management
| BBus CA | Chief Officer | Profile | |
| Alex Arzeno | VP Relations | Profile | |
| Victoria Gavrilenko | Operations Manager | Profile | |
| Anna Turkington | Vice Marketing | Profile | |
| Callistus Sequeira | Vice Operations | Profile | |
| Doug Heath | Vice Sales | Profile |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.